Grant: Fellowship - Priority Announcement: Infection and Immunity
University of Calgary
$135,000.00
Identification and mitigation of oxidized phospholipids as a novel mediator of neurodegeneration in the central nervous system.
EF 2019-20
Résumé
Multiple sclerosis (MS) is currently an incurable autoimmune disease of the brain and spinal cord. Patients are afflicted with deteriorating MS for life. We aim to explore new mechanisms that cause nerve destruction during MS to provide better treatments for all MS patients. During MS, inflammation and myelin loss around neurons can result in the production of harmful molecules such as oxidized lipid molecules, which are reactive and can kill cells to cause permanent damage in the lesions. It is therefore important to understand the biology of these reactive lipid molecules in MS lesions, and if their removal by immune debris-removing cells such as the microglia may slow or stop disease progression. In addition, as MS is a life-long disease, it is important to evaluate if the ability of immune cells to remove oxidized lipid molecules becomes worse during disease progression, and if so, how this process may be rejuvenated. Thus, we propose new models to interrogate the harmful consequences of reactive lipid molecules in the central nervous system and the capacity of immune cells to help their clearance. We will also test for promising therapeutic targets and aim to repurpose cost-effective generic medications such as indapmide to promote neuroprotection from these oxidized lipid molecule.
Programme
Fellowship - Priority Announcement: Infection and Immunity
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
417675
Name
Dong Yifei
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Identification and mitigation of oxidized phospholipids as a novel mediator of neurodegeneration in the central nervous system.
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement: Infection and Immunity
Keyworddelim
Flow Cyometry; Inflammation; Microglia; Microscopy; Mouse Model; Multiple Sclerosis; Neurodegeneration; Oxidized Phosphatidylcholine; Rna Sequencing; Spinal Cord
Abstract
Multiple sclerosis (MS) is currently an incurable autoimmune disease of the brain and spinal cord. Patients are afflicted with deteriorating MS for life. We aim to explore new mechanisms that cause nerve destruction during MS to provide better treatments for all MS patients. During MS, inflammation and myelin loss around neurons can result in the production of harmful molecules such as oxidized lipid molecules, which are reactive and can kill cells to cause permanent damage in the lesions. It is therefore important to understand the biology of these reactive lipid molecules in MS lesions, and if their removal by immune debris-removing cells such as the microglia may slow or stop disease progression. In addition, as MS is a life-long disease, it is important to evaluate if the ability of immune cells to remove oxidized lipid molecules becomes worse during disease progression, and if so, how this process may be rejuvenated. Thus, we propose new models to interrogate the harmful consequences of reactive lipid molecules in the central nervous system and the capacity of immune cells to help their clearance. We will also test for promising therapeutic targets and aim to repurpose cost-effective generic medications such as indapmide to promote neuroprotection from these oxidized lipid molecule.
Competitiondate
201910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Dong, Yifei
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~